Comments on: XIENCE V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years

Comments on: XIENCE V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years http://prwire.hashout.org/2008/05/14/xience-v-drug-eluting-stent-from-abbott-outperforms-market-leading-stent-in-reducing-major-adverse-cardiac-events-at-two-years/ Mon, 06 Oct 2008 17:18:29 +0000 http://wordpress.org/?v=2.3.3